Skip to main content

Advertisement

Fig. 2 | Radiation Oncology

Fig. 2

From: Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer

Fig. 2

Validation of miR-29a-3p and miR-150-5p. (a) miR-29a-3p and (b) miR-150-5p expression significantly decreased in the circulation during the course of thoracic RT in the validation cohort (overall p = 0.032 and 0.036, respectively). P-values displayed are post-hoc comparisons between 0 and 20 Gy, 20 and 40 Gy, and 0 and 40 Gy. Higher dCp scores represent higher expression levels. Error bars represent standard deviation

Back to article page